Management of Statin-Intolerant Female Patients with Elevated LDL

Initial Assessment and Statin Re-challenge Strategy

The American College of Cardiology recommends attempting at least 2-3 different statins at varying doses before confirming genuine statin intolerance, as true cause-effect correlation between muscle pain and statin use occurs in only 1% of patients 2, 3
Review all concomitant medications for drug interactions that may contribute to myalgia, as recommended by the American College of Cardiology 4

The American College of Cardiology recommends ezetimibe 10 mg daily as the preferred first-line alternative for statin-intolerant patients, providing an 18% LDL-C reduction as monotherapy 1
Ezetimibe inhibits cholesterol absorption in the small intestine via NPC1L1 protein blockade, and is generally well-tolerated with minimal adverse effects 1
The American College of Cardiology notes that ezetimibe has demonstrated cardiovascular outcomes benefit in the IMPROVE-IT trial, reducing major cardiovascular events in post-ACS patients 1

The American Heart Association recommends prescription niacin (not over-the-counter formulations) to lower total cholesterol and raise HDL-C, as a Class IIa recommendation for high-risk women with low HDL or elevated non-HDL cholesterol 5, 6
Fibrates (fenofibrate) are effective for lowering triglycerides and are generally well-tolerated in women, according to the American Heart Association 5, 6

The American College of Cardiology recommends PCSK9 inhibitors (evolocumab or alirocumab) for patients requiring aggressive LDL lowering who remain intolerant to statins, providing 50-60% additional LDL-C reduction 1
The American College of Cardiology notes that PCSK9 inhibitors have demonstrated cardiovascular outcomes benefit in the FOURIER and ODYSSEY Outcomes trials, with no treatment heterogeneity by sex 4

The American College of Cardiology recommends reducing saturated fat to <7% of total calories and cholesterol intake to <200 mg/day, as a Class I recommendation for all women requiring cholesterol control 7
Regular physical activity (at least 30 minutes most days) and achieving/maintaining a healthy body weight are also recommended by the American Heart Association 5, 6, 7

The American College of Cardiology recommends rechecking lipid panel 4-12 weeks after initiating alternative therapy, with a target LDL-C <100 mg/dL for high-risk women, and consideration of <70 mg/dL for very high-risk patients 7
Assessing adherence and tolerability at each visit is also recommended by the European Heart Journal 2, 3